Department of Endocrinology, Institute of Endocrine and Metabolic Disease, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, Clinical Research Hospital of Chinese Academy of Sciences (Hefei), University of Science and Technology of China, Hefei, Anhui, China.
Anhui Provincial Key Laboratory of Metabolic Health and Panvascular Diseases, Hefei, Anhui, China.
J Cardiovasc Pharmacol. 2024 Sep 1;84(3):289-302. doi: 10.1097/FJC.0000000000001602.
Unhealthy lifestyles have placed a significant burden on individuals' cardiovascular health. Anthocyanins are water-soluble flavonoid pigments found in a wide array of common foods and fruits. Anthocyanins have the potential to contribute to the prevention and treatment of cardiovascular disease by improving lipid profiles and vascular function, reducing blood glucose levels and blood pressure, and inhibiting inflammation. These actions have been demonstrated in numerous clinical and preclinical studies. At the cellular and molecular level, anthocyanins and their metabolites could protect endothelial cells from senescence, apoptosis, and inflammation by activating the phosphoinositide 3-kinase/protein kinase B/endothelial nitric oxide synthases, silent information regulator 1 (SIRT1), or nuclear factor erythroid2-related factor 2 pathways and inhibiting the nuclear factor kappa B, Bax, or P38 mitogen-activated protein kinase pathways. Furthermore, anthocyanins prevent vascular smooth muscle cell from platelet-derived growth factor -induced or tumor necrosis factor-α-induced proliferation and migration by inhibiting the focal adhesion kinase and extracellular regulated protein kinases signaling pathways. Anthocyanins could also attenuate vascular inflammation by reducing the formation of oxidized lipids, preventing leukocyte adhesion and infiltration of the vessel wall, and macrophage phagocytosis of deposited lipids through reducing the expression of cluster of differentiation 36 and increasing the expression of ATP-binding cassette subfamily A member 1 and ATP-binding cassette subfamily G member 1. At the same time, anthocyanins could lower the risk of thrombosis by inhibiting platelet activation and aggregation through down-regulating P-selectin, transforming growth factor-1, and CD40L. Thus, the development of anthocyanin-based supplements or derivative drugs could provide new therapeutic approaches to the prevention and treatment of vascular diseases.
不健康的生活方式给个人的心血管健康带来了巨大的负担。花色苷是一种广泛存在于常见食物和水果中的水溶性类黄酮色素。花色苷通过改善血脂谱和血管功能、降低血糖水平和血压以及抑制炎症,有可能有助于预防和治疗心血管疾病。大量的临床和临床前研究已经证明了这一点。在细胞和分子水平上,花色苷及其代谢物可以通过激活磷脂酰肌醇 3-激酶/蛋白激酶 B/内皮型一氧化氮合酶、沉默信息调节因子 1(SIRT1)或核因子红细胞 2 相关因子 2 途径以及抑制核因子 κB、Bax 或 P38 丝裂原活化蛋白激酶途径来保护内皮细胞免受衰老、凋亡和炎症的影响。此外,花色苷通过抑制黏着斑激酶和细胞外调节蛋白激酶信号通路,防止血管平滑肌细胞受到血小板衍生生长因子或肿瘤坏死因子-α诱导的增殖和迁移。花色苷还可以通过减少氧化脂质的形成、防止白细胞黏附和血管壁浸润以及巨噬细胞吞噬沉积的脂质,来减轻血管炎症,其机制是通过降低 CD36 的表达和增加 ABCA1 和 ABCG1 的表达。同时,花色苷通过下调 P-选择素、转化生长因子-β1 和 CD40L,抑制血小板激活和聚集,从而降低血栓形成的风险。因此,开发基于花色苷的补充剂或衍生物药物可能为预防和治疗血管疾病提供新的治疗方法。